Agk-2 97.0%(HPLC)
97.0%(HPLC)
Properties
| Vapour pressure | 0.0±2.1 mmHg at 25℃ |
| Assay Purity | >97%(HPLC) |
| Refractive index | 1.718 |
| B pt. | 675.1±55.0 ℃ at 760 mmHg |
| Density | 1.4±0.1 g/cm3 |
Safety Information
| Hazard Statement(s) | H302 -H312-H332-H315-H319 |
| Precautionary Statement | P501 + P270 + P302 + P352 +P280 + P264 + P337 + P313 +P305 + P351 + P338 + P362 + P364 + P332 + P313 + P301 + P312 + P330 |
| Symbol |
|
| Signal word | Warning |
| Flash point | 362.1±31.5℃ |
| Storage Temp. | Store at 0-10℃ |
| Packaging | Glass bottle |
Description
Recommended products
2-Cyano-3-[5-(25-dichlorophenyl)furan-2-yl]-N-(quinolin-5-yl)acrylamide
Application
AGK2 is a SIRT2 inhibitor. AGK2 has been used in a study to determine that SIRT2 inhibition induces cell death and decreases the intracellular ATP level. AGK2 also rescues dopamine neurons from -synuclein toxicity in Parkinsons disease models.
Purpose
For R&D use onlynot for drug household or other uses.
General Description
AGK 2 is a potent and selective histone deacetylase inhibitor or SIRT2 inhibitor which may be used in the treatment of parkinsons disease preventing cell death.
Documents
| SDS |
| COA |
| Specification |
| Bulk quote order form |